Brief: Virpax Pharmaceuticals On April 2, Got Letter From Nasdaq Stating That Company Was Not In Compliance With Nasdaq Listing Rule
April 3 (Reuters) - Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX PHARMACEUTICALS INC - ON APRIL 2, GOT LETTER FROM
NASDAQ
STATING THAT COMPANY WAS NOT IN COMPLIANCE WITH NASDAQ LISTING
RULE
Source text for Eikon: ID:n0001213900-24-029811
Further company coverage: VRPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study